Expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation

Abstract

In order to investigate the changes in the expression of extracellular signal-regulated kinase (ERK1/ERK2) and angiotensin-converting enzyme (ACE) in the patients with atrial fibrillation (AF), 52 patients with rheumatic heart diseases were examined. Nineteen patients had chronic persistent AF (AF>-6 months, CAF), 12 patients had paroxymal AF (PAF) and 21 patients had no history of AF. The ERK expression was detected at the mRNA level by reverse transcription polymerase chain reaction, at the protein level by Western blotting and at atrial tissue level by immunohistochemistry. ERK-activating kinases (MEK1/2) and ACE were determined by Western blotting techniques. The expression of ERK2-mRNA was increased in the patients with CAF (74±19 U vs sinus rhythm: 32±24 U,P<0.05). Activated ERK1/ERK2 and MEK1/2 were increased to more than 150% in the patients with AF compared to those with sinus rhythm. No significant difference between CAF and PAF was found. The expression of ACE was three-fold increased in the patients with CAF compared to those with sinus rhythm. Patients with AF showed an increased expression of ERK1/ERK2 in atrial interstitial cells and marked atrial fibrosis. An ACE-dependent increase in the amounts of activated ERK1/ERK2 in atrial interstitial cells may be one of molecular mechanisms for the development of atrial fibrosis in the patients with AF. These findings may have important impact on the treatment of AF.

Keywords

atrial fibrillation / angiotensin-converting enzyme / extracellular signal-regulated kinase

References

[1] MorilloC A, KleinG J, JonesD L, et al.. Chronic rapid atrial pacing: structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation, 1995, 91: 1588-1588

[2] WijffelsM C E F, KirchhofC J H J, DorlandR, et al.. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation, 1995, 92: 1954-1954

[3] HobbsW J C, FynnS, ToddD M, et al.. Reversal of atrial electrical remodeling after cardioversion of persistent atrial fibrillation in human. Circulation, 2000, 101: 1145-1145

[4] ThijssenV L J L, AusmaJ, LiuG S, et al.. Structural changes of atrial myocardium during chronic atrial fibrillation. Cardiovasc Pathol, 2001, 9: 17-17

[5] LiD, FarehS, LeungT K, et al.. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation, 1999, 100: 87-87

[6] SugdenP H, ClerkA. Regulation of the ERK subgroup of MAP kinase cascade through G protein-coupled receptors. Cell Signal, 1997, 9: 337-337

[7] YamazakiT, KomuroI, KudohS, et al.. Mechanical stress activates protein kinase cascade of phosphorylation in neonatal rat cardiac myocytes. J Clin Invest, 1995, 96: 438-438

[8] McEwanP E, GrayG A, SherryL, et al.. Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial perivascular fibrosis in vivo. Circulation, 1998, 98: 2765-2765

[9] YamazakiT, KomuroI, KudohS, et al.. Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy. J Biol Chem, 2004, 271: 3221-3221

[10] WhiteC W, KerberR E, WeissH R, et al.. The effects of atrial fibrillation on atrial pressure-volume and flow relationships. Circ Res, 1982, 52: 205-205

[11] SugdenP H, ClerkA. Stress-responsive mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ Res, 1998, 83: 345-345

[12] ChenA, DaviesB H. UV irradiation activates JNK and increases alphal (I) collagen gene expression in rat hepatic stellate cells. J Biol Chem, 1999, 274: 158-158

[13] van EickelsM, GroheC, LobbertK, et al.. Angiotensin converting enzyme inhibitors block mitogenic signalling pathways in rat cardiac fibroblasts. Naunyn Schmiedebergs Arch Pharmacol, 1999, 359: 394-394

[14] AndreasG, MarcoA, ChristophR, et al.. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. Circulation, 2000, 101: 2678-2678

[15] CookS A, SugdenP H, ClerkA. Activation of c-Jun N-terminal kinases and p38-mitogen-activated protein kinases in human heart failure secondary to ischaemic heart diseases. J Moll Cell Cardiol, 1999, 31: 1429-1429

[16] CommunalC, ColucciW S, SawyerD B, et al.. Differential modulation of mitogen-activated protein kinases and mitogen-activated protein kinases phosphatases in failing human myocardium (abstr). Circulation, 1999, 100: I-199